In a significant stride towards advancing nanoparticle drug delivery manufacturing technology, German pharmatech company, leon-nanodrugs GmbH (LEON), proudly announces a pioneering technical evaluation by CMAC, University of Strathclyde.

Company’s global professional services organization completes more than 100 successful customer go-lives within a single year.

The widespread use of artificial intelligence (AI) in medical decision-making tools has led to an update of the TRIPOD guidelines for reporting clinical prediction models. The new TRIPOD+AI guidelines are launched in the BMJ today.

Breakthrough medium delivers speed and scale to CAR-T cell therapy manufacturers.

Collaboration aims to provide researchers cutting-edge tools to enable transformational monitoring of key biomarkers in solid tissue transplants.

Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics.

Access to compound collection enables greater flexibility and efficiencies in screening and target identification.

China shifts its focus to thermal imaging technologies, securing 50% of worldwide shipments in 2023.

Metrohm is proud to announce the expansion of its OMNIS platform with the addition of near-infrared spectroscopy (NIRS) capabilities.

With the announcement of a $500,000 donation to the UCSC Genomics Institute in support of the UCSC Paleogenomics Lab, Colossal continues to expand its ancient DNA academic collaborations.